266 related articles for article (PubMed ID: 21843312)
1. Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas.
Liu W; Lv G; Li Y; Li L; Wang B
J Exp Clin Cancer Res; 2011 Aug; 30(1):76. PubMed ID: 21843312
[TBL] [Abstract][Full Text] [Related]
2. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.
Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C
Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.
Arap W; Knudsen E; Sewell DA; Sidransky D; Wang JY; Huang HJ; Cavenee WK
Oncogene; 1997 Oct; 15(17):2013-20. PubMed ID: 9366518
[TBL] [Abstract][Full Text] [Related]
6. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas.
Tani Y; Inoshita N; Sugiyama T; Kato M; Yamada S; Shichiri M; Hirata Y
Eur J Endocrinol; 2010 Oct; 163(4):523-9. PubMed ID: 20616110
[TBL] [Abstract][Full Text] [Related]
9. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
10. Frequent alterations of cell-cycle regulators in astrocytic tumors as detected by molecular genetic and immunohistochemical analyses.
Nakamura M; Konishi N; Hiasa Y; Tsunoda S; Nakase H; Tsuzuki T; Aoki H; Sakitani H; Inui T; Sakaki T
Brain Tumor Pathol; 1998; 15(2):83-8. PubMed ID: 10328544
[TBL] [Abstract][Full Text] [Related]
11. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
[TBL] [Abstract][Full Text] [Related]
12. Bmi-1 regulates the migration and invasion of glioma cells through p16.
Liang J; Wang P; Xie S; Wang W; Zhou X; Hu J; Shi Q; Zhang X; Yu R
Cell Biol Int; 2015 Mar; 39(3):283-90. PubMed ID: 25262972
[TBL] [Abstract][Full Text] [Related]
13. γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16
Zainuddin A; Chua KH; Tan JK; Jaafar F; Makpol S
J Physiol Biochem; 2017 Feb; 73(1):59-65. PubMed ID: 27743340
[TBL] [Abstract][Full Text] [Related]
14. RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells.
Qiu G; Sun W; Zou Y; Cai Z; Wang P; Lin X; Huang J; Jiang L; Ding X; Hu G
Tumour Biol; 2015 Sep; 36(10):8231-8. PubMed ID: 26002575
[TBL] [Abstract][Full Text] [Related]
15. BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.
Bai J; Mei PJ; Liu H; Li C; Li W; Wu YP; Yu ZQ; Zheng JN
J Cancer Res Clin Oncol; 2012 Jun; 138(6):991-8. PubMed ID: 22362300
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.
Chakravarti A; Delaney MA; Noll E; Black PM; Loeffler JS; Muzikansky A; Dyson NJ
Clin Cancer Res; 2001 Aug; 7(8):2387-95. PubMed ID: 11489817
[TBL] [Abstract][Full Text] [Related]
17. The effect of cyclin D expression on cell proliferation in human gliomas.
Zhang X; Zhao M; Huang AY; Fei Z; Zhang W; Wang XL
J Clin Neurosci; 2005 Feb; 12(2):166-8. PubMed ID: 15749420
[TBL] [Abstract][Full Text] [Related]
18. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.
Sibin MK; Bhat DI; Narasingarao KV; Lavanya Ch; Chetan GK
Tumour Biol; 2015 Sep; 36(10):7607-14. PubMed ID: 25921285
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
